Company Profile
Vaxxinity Stock Price, News & Catalysts
- Ticker:
- VAXX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.00 USD (-99.61%)
Close
Last updated: August 17, 2026
—
Market cap
Why the stock is moving
As of Aug 17, 2026, VAXX closed down 99.6% at $0.0001. No new same-company headline was identified in the current news window.
Company overview
Business overview
Vaxxinity was a vaccine and immunotherapy company focused on synthetic vaccine development before its business was wound down and restructured. Its story reflected the challenge of translating platform ambition into commercial value.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ before restructuring, Vaxxinity sat in vaccine biotechnology.
Business Model Characteristics
The business depended on platform validation, clinical progress, and investor patience for a long-duration vaccine story.
Position Within the Biotechnology Landscape
Vaxxinity is best treated as a historical vaccine-platform case rather than a live catalyst leader.
Future catalysts
- Vaxxinity’s catalysts are its vaccine platform and any strategic update that clarifies the company’s next direction. The stock needs a clearer answer on how the platform becomes value-generating.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Vaxxinity (VAXX)?
Vaxxinity (VAXX) most recently closed at 0.00 USD, a -99.61% move versus the previous session.
What does Vaxxinity do?
Vaxxinity was a vaccine and immunotherapy company focused on synthetic vaccine development before its business was wound down and restructured. Its story reflected the challenge of translating platform ambition into commercial value.
On which exchange is VAXX stock listed?
Vaxxinity (VAXX) is associated with NASDAQ, United States, Biopharma.
What is Vaxxinity?
Vaxxinity’s catalysts are its vaccine platform and any strategic update that clarifies the company’s next direction.
Which conditions is Vaxxinity targeting with Vaxxinity?
Vaxxinity’s catalysts are its vaccine platform and any strategic update that clarifies the company’s next direction.
How does Vaxxinity describe recent progress with Vaxxinity?
Vaxxinity’s catalysts are its vaccine platform and any strategic update that clarifies the company’s next direction.
What future catalysts are investors watching for Vaxxinity?
Vaxxinity’s catalysts are its vaccine platform and any strategic update that clarifies the company’s next direction. The stock needs a clearer answer on how the platform becomes value-generating.